These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 15485606)
1. Treatment of lipids and type 2 diabetes. Hermayer KL Curr Cardiol Rep; 2004 Nov; 6(6):443-50. PubMed ID: 15485606 [TBL] [Abstract][Full Text] [Related]
2. Management of Lipids in Patients with Diabetes. Mbue ND; Mbue JE; Anderson JA Nurs Clin North Am; 2017 Dec; 52(4):605-619. PubMed ID: 29080581 [TBL] [Abstract][Full Text] [Related]
6. [Lipids: diagnosis and therapy in type 2 diabetes]. Wascher TC; Paulweber B; Toplak H; Saely C; Drexel H Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():28-30. PubMed ID: 23250461 [TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering therapy in people with type 2 diabetes. Colagiuri S; Best J Curr Opin Lipidol; 2002 Dec; 13(6):617-23. PubMed ID: 12441885 [TBL] [Abstract][Full Text] [Related]
8. Management of dyslipidemia in adults with diabetes. American Diabetes Association. Diabetes Care; 1998 Jan; 21(1):179-82. PubMed ID: 9538989 [No Abstract] [Full Text] [Related]
9. Lipids and atherogenesis in diabetes mellitus. Betteridge DJ Atherosclerosis; 1996 Jul; 124 Suppl():S43-7. PubMed ID: 8831915 [TBL] [Abstract][Full Text] [Related]
10. Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones. Florkowski CM Am J Cardiovasc Drugs; 2002; 2(1):15-21. PubMed ID: 14727995 [TBL] [Abstract][Full Text] [Related]
11. Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong. Lee VW; Ho IC; Chan WS; Tam KY; Lee KK Am J Cardiovasc Drugs; 2008; 8(3):199-205. PubMed ID: 18533740 [TBL] [Abstract][Full Text] [Related]
12. Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetes. Aguilar-Salinas CA; Mehta R; Gomez-Diaz RA Curr Diab Rep; 2012 Jun; 12(3):221-3. PubMed ID: 22451238 [No Abstract] [Full Text] [Related]
13. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk. Duntas L; Kolovou G Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018 [No Abstract] [Full Text] [Related]
14. Lipid disorders in NIDDM: implications for treatment. Taskinen MR; Smith U J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851 [TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
16. Diabetic dyslipidemia. Kreisberg RA Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665 [TBL] [Abstract][Full Text] [Related]
17. Lipids and diabetes mellitus: a review of therapeutic options. Goguen JM; Leiter LA Curr Med Res Opin; 2002; 18 Suppl 1():s58-74. PubMed ID: 12365820 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Cottrell DA; Marshall BJ; Falko JM Curr Opin Cardiol; 2003 Jul; 18(4):301-8. PubMed ID: 12858129 [TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering therapy and macrovascular disease in diabetes mellitus. Garg A Diabetes; 1992 Oct; 41 Suppl 2():111-5. PubMed ID: 1526329 [TBL] [Abstract][Full Text] [Related]
20. PCSK9 inhibitors- A new age in lipid management? Grant PJ Diab Vasc Dis Res; 2017 May; 14(3):171. PubMed ID: 28467196 [No Abstract] [Full Text] [Related] [Next] [New Search]